CVRx Inc (NASDAQ:CVRX) — Market Cap & Net Worth
Market Cap & Net Worth: CVRx Inc (CVRX)
CVRx Inc (NASDAQ:CVRX) has a market capitalization of $67.40 Million ($67.40 Million) as of September 25, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #20826 globally and #4701 in its home market, demonstrating a -16.23% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying CVRx Inc's stock price $2.53 by its total outstanding shares 26641597 (26.64 Million). Also see CVRx Inc balance sheet assets for a full breakdown of the balance sheet.
CVRx Inc Market Cap History: 2021 to 2026
CVRx Inc's market capitalization history from 2021 to 2026. Data shows change from $325.83 Million to $67.40 Million (-36.80% CAGR). Also see CVRx Inc cash flow conversion for how efficiently the company converts equity into cash flow.
Index Memberships
CVRx Inc is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
NASDAQ Health Care
IXHC
|
$2.64 Trillion | 0.00% | #597 of 976 |
|
NASDAQ Composite
IXIC
|
$42.16 Trillion | 0.00% | #1997 of 3165 |
Weight: CVRx Inc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
CVRx Inc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how CVRx Inc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check today's stock price for CVRx Inc for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
3.34x
CVRx Inc's market cap is 3.34 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2021 | $325.83 Million | $13.04 Million | -$43.08 Million | 24.99x | N/A |
| 2022 | $488.87 Million | $22.47 Million | -$41.43 Million | 21.76x | N/A |
| 2023 | $837.61 Million | $39.30 Million | -$41.20 Million | 21.32x | N/A |
| 2024 | $337.55 Million | $51.29 Million | -$59.97 Million | 6.58x | N/A |
| 2025 | $189.16 Million | $56.65 Million | -$53.31 Million | 3.34x | N/A |
Competitor Companies of CVRX by Market Capitalization
Companies near CVRx Inc in the global market cap rankings as of September 25, 2026. Review CVRX tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to CVRx Inc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #129 globally with a market cap of $175.75 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #229 globally with a market cap of $109.30 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #237 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
- Stryker Corporation (NYSE:SYK): Ranked #242 globally with a market cap of $103.47 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #129 | Abbott Laboratories | NYSE:ABT | $175.75 Billion | $101.07 |
| #229 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $88.51 |
| #237 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
| #242 | Stryker Corporation | NYSE:SYK | $103.47 Billion | $269.75 |
CVRx Inc Historical Marketcap From 2021 to 2026
Between 2021 and today, CVRx Inc's market cap moved from $325.83 Million to $ 67.40 Million, with a yearly change of -36.80%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $67.40 Million | -64.37% |
| 2025 | $189.16 Million | -43.96% |
| 2024 | $337.55 Million | -59.70% |
| 2023 | $837.61 Million | +71.34% |
| 2022 | $488.87 Million | +50.04% |
| 2021 | $325.83 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 25th, 2026 the market cap of CVRx Inc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $67.40 Million USD |
| MoneyControl | $67.40 Million USD |
| MarketWatch | $67.40 Million USD |
| marketcap.company | $67.40 Million USD |
| Reuters | $67.40 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About CVRx Inc
CVRx, Inc., a commercial-stage medical device company, engages in developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases in the United States, Germany, and internationally. The company offers Barostim, an implantable device that delivers electrical pulses to baroreceptors located in the wall of the carotid artery to counteract decreased … Read more